mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.01 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.02 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |